STAR ARMY

Sci-fi roleplaying and worldbuilding community

User Tools

Site Tools


items:drugs:myazakascin

Myazakascin

A drug created and manufactured by Advancer Enterprises, it entered Advancer's pharmaceutical catalog in late YE 45. Myazakascin is a novel gaseous antibiotic that can be used to disinfect both the exterior and interior of the body owing to its non-toxic nature when appropriately diluted.

»Optional Image«
Year Created: YE 45
Designer / Manufacturer: Advancer Enterprises
Nomenclature: AE-N29
Price: 40 KS per 100ml canister

History

Myazakascin was conceived to fill a gap in the market for a versatile, non-toxic antibiotic capable of treating a range of infections. Advancer Enterprises invested heavily in R&D, collaborating with leading microbiologists and pharmacologists. After years of rigorous testing and clinical trials, Myazakascin was born. It was designed to be easily administered, either through inhalation or topical application, providing a user-friendly experience that aligns with Advancer's philosophy.

Usage

Myazakascin functions by disrupting bacterial cell walls, leading to bacterial cell death. It is particularly effective in treating respiratory tract infections, skin infections, and wound sterilization. The drug is administered through specialized canisters that release a controlled amount of the gaseous antibiotic. For respiratory infections, a 5-minute inhalation session is recommended, while for topical applications, a 2-minute exposure is sufficient. The gas is sold in 100ml canisters, each containing a concentration of 50mg/ml.

Side Effects

Myazakascin is engineered to minimize side effects, aligning with Advancer's commitment to patient safety. Mild skin irritation and temporary changes in taste are the most common side effects. Due to its cryogenic nature, it must be stored at temperatures below -20°C to maintain its efficacy and safety. Specialized storage units are available from Advancer, ensuring that the drug remains in optimal condition until use.

Overdose

Overexposure to Myazakascin can result in severe respiratory distress and potential asphyxiation. The overdose threshold is estimated to be around 500mg to 750mg, which equates to a 10 to 15-minute continuous inhalation session from a 100ml canister with a concentration of 50mg/ml. Immediate medical intervention is crucial, often involving respiratory support and detoxification procedures.

OOC Notes

Star Army Logistics
Supply ClassificationClass J - MEDICAL BIOLOGICAL
Drugs, Medicines, and Pharmaceuticals
Drug Name(s)Myazakascin
Route of Administrationnasal inhalation, topical (skin)
Drug ClassAntibiotic
Products & Items Database
Product Categoriesdrugs
Product NameMyazakascin
NomenclatureAE-N29
ManufacturerAdvancer Enterprises
Year ReleasedYE 45
Price (KS)40.00 KS

Quality:
items/drugs/myazakascin.txt · Last modified: 2023/12/28 10:32 by wes